Q1 EPS Forecast for Privia Health Group Reduced by Analyst

Privia Health Group, Inc. (NASDAQ:PRVA) – Equities research analysts at Leerink Partnrs cut their Q1 2025 earnings estimates for Privia Health Group in a research report issued to clients and investors on Thursday, February 27th. Leerink Partnrs analyst W. Mayo now anticipates that the company will earn $0.07 per share for the quarter, down from their previous forecast of $0.08. The consensus estimate for Privia Health Group’s current full-year earnings is $0.14 per share. Leerink Partnrs also issued estimates for Privia Health Group’s Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.09 EPS, FY2025 earnings at $0.33 EPS, Q1 2026 earnings at $0.10 EPS, Q2 2026 earnings at $0.11 EPS, Q3 2026 earnings at $0.12 EPS, Q4 2026 earnings at $0.13 EPS and FY2027 earnings at $0.61 EPS.

Several other equities research analysts also recently weighed in on PRVA. Barclays upped their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. JMP Securities reissued a “market outperform” rating and issued a $26.00 price target on shares of Privia Health Group in a report on Friday, February 14th. Needham & Company LLC raised their price objective on shares of Privia Health Group from $25.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, February 28th. Piper Sandler raised their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday, February 28th. Finally, Macquarie began coverage on shares of Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective for the company. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, Privia Health Group presently has a consensus rating of “Buy” and a consensus price target of $26.47.

Privia Health Group Stock Up 2.2 %

PRVA stock opened at $25.52 on Monday. The company has a market capitalization of $3.06 billion, a P/E ratio of 255.23, a PEG ratio of 3.47 and a beta of 0.87. The company has a 50-day simple moving average of $22.61 and a 200 day simple moving average of $20.68. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $26.04.

Institutional Trading of Privia Health Group

A number of hedge funds have recently bought and sold shares of PRVA. Creative Planning lifted its stake in Privia Health Group by 27.1% during the third quarter. Creative Planning now owns 25,987 shares of the company’s stock valued at $473,000 after buying an additional 5,542 shares in the last quarter. International Assets Investment Management LLC lifted its position in shares of Privia Health Group by 1,720.9% in the third quarter. International Assets Investment Management LLC now owns 5,499 shares of the company’s stock worth $100,000 after purchasing an additional 5,197 shares in the last quarter. Olympiad Research LP purchased a new stake in shares of Privia Health Group in the third quarter worth approximately $195,000. GSA Capital Partners LLP lifted its position in shares of Privia Health Group by 228.1% in the third quarter. GSA Capital Partners LLP now owns 50,975 shares of the company’s stock worth $928,000 after purchasing an additional 35,439 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its position in shares of Privia Health Group by 402.9% in the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock worth $3,260,000 after purchasing an additional 143,446 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.